Kirsten Carroll appointed CEO; Stefan Heuser named CFO and Clayton Duncan named SVP, Commercialization Kandu Health achieves successful enrollment of the first 50 stroke survivors in its stroke recovery program CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc., a medical technology company elevating care for people affected by stroke and other ischemic diseases, […]
Other News
Dr. Jonathan Weinsaft Named Chief of the Greenberg Division of Cardiology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center
NEW YORK (June 14, 2023)— Dr. Jonathan Weinsaft, an esteemed physician-scientist who focuses on clinical research and cardiovascular imaging, has been appointed chief of the Greenberg Division of Cardiology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective July 1. The Greenberg Division of Cardiology, housed within the Weill […]
PECA Labs Achieves Successful First-In-Human Implant of the MASA Valve Pediatric Pulmonary Valved Conduit in U.S. Clinical Trial
Novel Polymeric Valve Aims to Reduce Re-operations and Re-interventions PITTSBURGH–(BUSINESS WIRE)–PECA Labs, a medical device company reimagining vascular grafts and valves with durable polymeric cardiovascular devices designed to fit, grow, and last, today announced the successful first-in-human implant of the MASA Valve. Designed for pediatrics, the MASA Valve is a […]
DEEPER OUS Trial Evaluating Reflow Medical’s Bare Temporary Spur Stent System Shows Positive Results at Six Months
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Reflow Medical, Inc. announced the six-month results of the DEEPER OUS clinical trial (NCT03807531) evaluating the safety and efficacy of the Bare Temporary Spur Stent System. Results were presented at the annual Leipzig International Course (LINC) in Leipzig, Germany. Michael Lichtenberg, MD, FESC, Chief Medical Officer and […]
GORE INITIATES STUDY TO COMPARE THE GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS TO BARE METAL STENTS
The Gore VBX FORWARD Clinical Study aims to compare the VBX Stent Graft primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease. FLAGSTAFF, Ariz., June 13, 2023 /PRNewswire/ — W. L. Gore & Associates (Gore) announced today the initiation of the Gore VBX FORWARD Clinical Study (NCT05811364) […]
Casana Announces the Appointment of Shikha Anand, M.D., As Chief Medical Officer
Dr. Anand brings deep experience in developing patient-centered solutions to improve health; Company pursues second FDA clearance ROCHESTER, N.Y., June 13, 2023 (GLOBE NEWSWIRE) — Today, Casana, the industry leader in monitoring heart health through smart toilets, announced the appointment of Shikha Anand, M.D. MPH, as Chief Medical Officer. Casana is dedicated to […]
BIOTRONIK ANNOUNCED FIRST IMPLANT OF NEW IMPLANTABLE CARDIAC MONITOR WITH ARTIFICIAL INTELLIGENCE, TARGETING EFFICIENCY IN MONITORING FOR CARDIAC ARRHYTHMIAS
Montefiore Medical Center in New York performed the first global implantation of the new BIOMONITOR IV ICM LAKE OSWEGO, Ore., June 12, 2023 /PRNewswire/ — BIOTRONIK, a leader in implantable medical device technology, today announced the first global implantation of its BIOMONITOR IV implantable cardiac monitor (ICM). The procedure was conducted by Luigi Di Biase, MD, […]
Starlight Cardiovascular Appoints Paul G. Yock, MD to its Board of Directors
Company developing a cardiovascular medical device portfolio for underserved pediatric population SAN DIEGO, June 13, 2023 /PRNewswire/ — Paul G. Yock has joined the Starlight Cardiovascular Board of Directors. Dr. Yock is the Founder, Director Emeritus, and a Board Member of the Stanford Byers Center for Biodesign. He is the former Martha Meier Weiland […]
StemBioSys Announces Launch of CELLvo™ Atrial Cardiomyocyte, a Technological Leap Forward in Cardiotoxicity Screening
Developed in collaboration with REPROCELL, CELLvo™ Atrial Cardiomyocyte delivers non-genetically modified human heart cells that are chamber specific and derived from iPS (stem) cells SAN ANTONIO, June 13, 2023 /PRNewswire/ — StemBioSys, Inc. (StemBioSys) announced today the launch of CELLvo™ Atrial Cardiomyocyte, a “chamber specific” human induced pluripotent stem cell derived cardiomyocyte (hiPSC-CM) designed to […]
Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth Orlando
AdventHealth Orlando performs their first implant of Guardian™ System, revolutionizing cardiac care in Central Florida EATONTOWN, N.J. and ORLANDO, Fla., June 13, 2023 (GLOBE NEWSWIRE) — Avertix Medical, Inc. (“Avertix” or the “Company”), formerly known as Angel Medical Systems, Inc., a company focused on improving long-term management and outcomes of high-risk coronary […]



